Mauna Kea Technologies SA
PAR:ALMKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Mauna Kea Technologies SA
Pre-Tax Income
Mauna Kea Technologies SA
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Pre-Tax Income
-€10.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Pre-Tax Income
-€28.8m
|
CAGR 3-Years
-139%
|
CAGR 5-Years
-89%
|
CAGR 10-Years
-41%
|
|
|
Biomerieux SA
PAR:BIM
|
Pre-Tax Income
€525.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
12%
|
|
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
Pre-Tax Income
€122k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Pre-Tax Income
-€3.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Pre-Tax Income
€1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Mauna Kea Technologies SA
Glance View
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France and currently employs 56 full-time employees. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
See Also
What is Mauna Kea Technologies SA's Pre-Tax Income?
Pre-Tax Income
-10.5m
EUR
Based on the financial report for Jun 30, 2025, Mauna Kea Technologies SA's Pre-Tax Income amounts to -10.5m EUR.
What is Mauna Kea Technologies SA's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
3%
Over the last year, the Pre-Tax Income growth was 19%. The average annual Pre-Tax Income growth rates for Mauna Kea Technologies SA have been 7% over the past three years , 5% over the past five years , and 3% over the past ten years .
